Olivia Haller

Research Interests

Cancer Biology and Clinical Oncology Neuroscience, Behaviour and Brain Health Road Safety Human Factors

Miss Olivia Haller

Research Officer

Office of Engineering and Information Technology

College of Engineering and Information Technology

Dr Olivia Haller completed a PhD in Biomedicine in early 2025 at the University of Adelaide. During this time, she commenced work at the Centre for Automotive Safety Research (CASR) at Adelaide University, where she currently works as a crash investigator and research officer. In this role, Dr Haller contributes to multidisciplinary road safety research, including in-depth crash investigation. Her research interests centre on human factors in road crashes. She also brings expertise in academic literature synthesis, including the design and execution of comprehensive literature reviews and systematic reviews.

Road safety - Crash Investigation - EDR - Drug Driving - Offender Programs

Date Institution name Country Title
2021 - 2025 University of Adelaide Australia PhD in Biomedicine
2020 - 2020 University of Adelaide Australia Bachelor of Health and Medical Sciences (Honours) (First Class)
2016 - 2018 University of Adelaide Australia Bachelor of Health and Medical Sciences (Advanced)

Year Citation
2025 Haller, O. J., Semendric, I., Collins-Praino, L. E., Whittaker, A. L., & George, R. P. (2025). Changes in cognition and astrocytic reactivity in a female rodent model of chemotherapy-induced cognitive impairment are variable both acutely and chronically. Behavioural Brain Research, 480, 115391-1-115391-15.
DOI Scopus3 WoS3 Europe PMC2
2025 Semendric, I., Barker, T. H., Haller, O. J., Pollock, D., Collins-Praino, L. E., & Whittaker, A. (2025). Prevalence of cancer-related cognitive impairment in pediatric patients and survivors: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 176, 106283-1-106283-33.
DOI Scopus3 WoS3 Europe PMC1
2023 Haller, O. J., Semendric, I., George, R. P., Collins-Praino, L. E., & Whittaker, A. L. (2023). The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models – a systematic review. Neuroscience & Biobehavioral Reviews, 148, 105120-1-105120-37.
DOI Scopus11 WoS10 Europe PMC7
2023 Semendric, I., Pollock, D., Haller, O., George, R., Collins-Praino, L., & Whittaker, A. (2023). "Chemobrain" in childhood cancer survivors - the impact on social, academic, and daily living skills: a qualitative systematic review. Supportive Care in Cancer, 31(9), 532-1-532-15.
DOI Scopus14 WoS13 Europe PMC7
2022 Semendric, I., Pollock, D., Haller, O., George, R., Collins-Praino, L., & Whittaker, A. (2022). ‘‘Chemobrain’’ in childhood cancer survivors - the impact on social, academic, and daily living skills: a qualitative systematic review protocol. JBI Evidence Synthesis, 20(1), 222-228.
DOI Scopus3 WoS3 Europe PMC3

Year Citation
2025 Elsegood, M., Haller, O., Ponte, G., Doecke, S., & Baraky, A. (2025). Collection and analysis of EDR data from crash-involved vehicles: 2024 summary report (CASR248). Adelaide: Centre for Automotive Safety Research.

Year Citation
2021 Haller, O., Whittaker, A., George, R., Semendric, I., & Collins-Praino, L. (2021). Investigating the effects of anti-inflammatory agents in pre-clinical models of chemotherapy-induced cognitive impairment – a systematic review protocol. PROSPERO- registration no: CRD42021240789.
2021 Semendric, I., Haller, O., George, R., Pollock, D., Whittaker, A., & Collins-Praino, L. (2021). Experience of the impact of chemobrain in childhood cancer survivors: a qualitative systematic review protocol. PROSPERO 2021 CRD42021240573. PROSPERO.

Year Citation
2024 Haller, O., Semendric, I., Collins-Praino, L., Whittaker, A., & George, R. (2024). Changes in cognition and neuroinflammation in a rodent model of chemotherapy-induced cognitive impairment are variable both acutely and chronically.
DOI

Connect With Me

External Profiles

Other Links